Yukihiko Shirayama Selected Research

Yukihiko Shirayama Research Topics

Disease

22	Schizophrenia (Dementia Praecox) 01/2021 - 11/2002
8	Cognitive Dysfunction 02/2019 - 05/2008
7	Psychotic Disorders (Schizoaffective Disorder) 12/2021 - 06/2005
4	Major Depressive Disorder (Major Depressive Disorders) 12/2018 - 01/2013
4	Inflammation (Inflammations) 10/2018 - 10/2014
3	Treatment-Resistant Depressive Disorder 10/2018 - 12/2014
2	Tardive Dyskinesia 12/2021 - 10/2017
2	Mental Disorders (Mental Disorder) 12/2018 - 10/2007
1	Treatment-Resistant Schizophrenia 12/2021
1	Thymoma (Thymic Carcinoma) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2020
1	Alzheimer Disease (Alzheimer's Disease) 02/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2018
1	Mood Disorders (Mood Disorder) 01/2017
1	Infections 01/2017
1	Movement Disorders (Movement Disorder) 12/2015
1	Memory Disorders (Memory Loss) 12/2014
1	Gambling (Pathological Gambling) 12/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2014
1	Brain Infarction 11/2011
1	Genetic Translocation (Chromosomal Translocation) 02/2011
1	Schizotypal Personality Disorder 02/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2008
1	Hypothermia 06/2008
1	Hypersensitivity (Allergy) 09/2006
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2006
1	Substance-Related Disorders (Drug Abuse) 06/2005
1	Depressive Disorder (Melancholia) 01/2004
1	Hallucinations (Hallucination) 09/2003

Drug/Important Bio-Agent (IBA)

6	Dopamine (Intropin)FDA LinkGeneric 12/2021 - 06/2005
6	Antidepressive Agents (Antidepressants)IBA 10/2018 - 01/2004
6	Pharmaceutical PreparationsIBA 01/2017 - 09/2007
5	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 08/2004
3	Proteins (Proteins, Gene)FDA Link 12/2018 - 07/2007
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2018 - 04/2008
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2014 - 12/2011
3	Fluvoxamine (Luvox)FDA LinkGeneric 10/2012 - 05/2008
2	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021 - 12/2020
2	InflammasomesIBA 12/2020 - 11/2016
2	Donepezil (Aricept)FDA LinkGeneric 02/2019 - 07/2009
2	Glutamine (L-Glutamine)FDA Link 01/2017 - 07/2008
2	Glutamic Acid (Glutamate)FDA Link 01/2017 - 07/2008
2	Biomarkers (Surrogate Marker)IBA 07/2014 - 02/2014
2	Sigma-1 ReceptorIBA 10/2012 - 05/2008
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2011 - 06/2008
2	Risperidone (Risperdal Consta)FDA LinkGeneric 06/2010 - 09/2003
2	Methamphetamine (Desoxyn)FDA LinkGeneric 07/2007 - 06/2005
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	3,4-Dihydroxyphenylacetic AcidIBA 01/2021
1	Homovanillic AcidIBA 01/2021
1	Glycogen Synthase (Synthase I)IBA 01/2021
1	Glycogen Synthase Kinase 3IBA 01/2021
1	AcidsIBA 01/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2019
1	Galantamine (Galanthamine)FDA LinkGeneric 02/2019
1	Transcription Factors (Transcription Factor)IBA 12/2018
1	norketamineIBA 10/2018
1	Ketamine FDA LinkGeneric 10/2018
1	Haloperidol (Haldol)FDA LinkGeneric 10/2017
1	rhyncophyllineIBA 01/2017
1	Protons (Proton)IBA 01/2017
1	Inositol (Myoinositol)IBA 01/2017
1	tipepidineIBA 02/2016
1	beta-Arrestin 1IBA 12/2015
1	G-protein-coupled receptor kinase 6IBA 12/2015
1	LithiumIBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	Fatty Acid-Binding Protein 7IBA 12/2014
1	ramelteon (Rozerem)FDA Link 12/2014
1	TropomyosinIBA 10/2014
1	LigandsIBA 10/2014
1	Phosphotransferases (Kinase)IBA 10/2014
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 07/2014
1	brain-derived neurotrophic factor precursorIBA 02/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2014
1	Paroxetine (Paxil)FDA LinkGeneric 11/2011
1	Cilostazol (Pletal)FDA LinkGeneric 10/2011
1	Serine (L-Serine)FDA Link 02/2011
1	Amino Acids FDA Link 02/2011
1	BenzodiazepinesIBA 11/2010
1	Tropisetron (Navoban)IBA 06/2010
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 06/2010
1	Serotonin (5 Hydroxytryptamine)IBA 06/2008
1	N-Methylaspartate (NMDA)IBA 06/2008
1	5-HT1A Serotonin ReceptorIBA 06/2008
1	AntioxidantsIBA 04/2008
1	Glutathione (Reduced Glutathione)IBA 04/2008
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2007
1	Minocycline (Cyclops)FDA LinkGeneric 09/2007
1	MKC 231IBA 09/2007
1	Bromodeoxyuridine (BrdU)IBA 09/2006
1	Methylphenidate (Ritalin)FDA LinkGeneric 09/2006
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 09/2006
1	NRH - quinone oxidoreductase2IBA 06/2005
1	QuinonesIBA 06/2005
1	serotonin 6 receptorIBA 04/2004

Therapy/Procedure

1	Aftercare (After-Treatment) 12/2014
1	Therapeutics 10/2012